As a neurologist, Dr. Clelland, PhD, MD, MPhil, specializes in caring for patients with dementia, memory impairment and cognitive symptoms at the UCSF Memory & Aging Center. Her lab at the UCSF Weill Institute for Neurosciences develops novel therapies for neurodegenerative diseases. Her current work centers on creating novel CRISPR gene therapies for genetic forms of dementia and ALS, utilizing patient iPSCs to model disease, advanced sequencing technologies and cutting-edge CRISPR technologies to develop first-in-class gene therapies for CNS diseases. She has developed human model systems to revolutionize the way new biologics are discovered and validated. Dr. Clelland co-Chairs the NIH Somatic Cell Genome Engineering Consortium Steering Committee. She is the recipient of two national awards for neuroscience - The Alzheimer’s Association & NACC New Investigator Award and the American Neurologic Association’s Grass Foundation Award in Neuroscience.